Condensed Consolidated Balance Sheets (USD $)	Jun. 30, 2014	Dec. 31, 2013
Current Assets:
Cash	$ 2,713,635	$ 3,071,887
Trade accounts receivable less allowances of approximately $64,000 and $93,000, respectively	4,217,347	4,413,656
Receivables due from affiliated companies	832,431	536,402
Inventories, net	7,950,359	7,367,894
Prepaid expenses and other current assets	711,964	621,107
Deferred tax asset	52,551	64,665
Total Current Assets	16,478,287	16,075,611
Property, plant and equipment, net	5,220,618	5,116,441
Other Assets:
Trademarks, trade names, royalty rights, and patents, net	885,573	920,269
Other assets	179,173	130,803
Total Other Assets	1,064,746	1,051,072
Total Assets	22,763,651	22,243,124
Current Liabilities:
Accounts payable - trade	1,347,678	1,013,829
Current portion of long term debt	419,422	414,525
Income taxes payable	23,776	119,943
Accrued expenses payable	1,009,565	1,067,355
Total Current Liabilities	2,800,441	2,615,652
Deferred tax liability	206,743	237,635
Long term debt, less current portion	906,081	1,117,761
Total Liabilities	3,913,265	3,971,048
Shareholders' Equity:
Common stock - $.01 par value, 12,000,000 shares authorized; 8,914,274 and 8,749,888 shares issued	89,142	87,499
Additional paid in capital	9,131,952	8,805,460
Less cost of common stock in treasury, 0 and 79,941 shares, respectively		(65,029)
Accumulated other comprehensive loss	(262,663)	(266,456)
Retained earnings	9,676,343	9,482,128
Total Shareholders' Equity of Ocean Bio-Chem, Inc.	18,634,774	18,043,602
Noncontrolling interest	215,612	228,474
Total Shareholders' Equity	18,850,386	18,272,076
Total Liabilities and Shareholders' Equity	$ 22,763,651	$ 22,243,124